The pharmacology of myoclonus.
Pranzatelli
M R
MR
Snodgrass
S R
SR
D006916:5-Hydroxytryptophan / Q000627:therapeutic use; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D001921:Brain / Q000503:physiopathology; D004195:Disease Models, Animal; D006168:Guinea Pigs; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D009118:Muscimol; D009207:Myoclonus / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology; D009294:Narcotics; D010215:Papio; D011963:Receptors, GABA-A / Q000502:physiology; D011957:Receptors, Opioid / Q000502:physiology; D011985:Receptors, Serotonin / Q000502:physiology; D012701:Serotonin / Q000502:physiology; D013973:Thyrotropin-Releasing Hormone / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000502:physiology
D000927:Anticonvulsants; D009294:Narcotics; D011963:Receptors, GABA-A; D011957:Receptors, Opioid; D011985:Receptors, Serotonin; D001569:Benzodiazepines; D009118:Muscimol; D012701:Serotonin; D007980:Levodopa; D005680:gamma-Aminobutyric Acid; D013973:Thyrotropin-Releasing Hormone; D000324:Adrenocorticotropic Hormone; D006916:5-Hydroxytryptophan